Jesse Treu

Investor type:

Social media:

Available after registration.

Past investments

  • Epic Sciences
  • Colorescience
  • Esperion Therapeutics
  • Astute Medical
  • Exalys Therapeutics
  • WindMIL Therapeutics
  • Zyga Technology
  • Atara Biotherapeutics
  • VentiRx Pharmaceuticals
  • Celtaxsys
  • Truvian Sciences
  • Gene Sciences, Inc.
  • Kona Medical
  • Veracyte
  • CoLucid Pharmaceuticals
  • Dicerna Pharmaceuticals
  • NovaDigm Therapeutics
  • Benvenue Medical
  • Miramar Labs
  • Ocunexus Therapeutics
  • Cotera
  • Regado Biosciences
  • Obalon Therapeutics
  • Sequent Medical
  • Marinus Pharmaceuticals
  • ReVision Optics
  • Neothetics
  • Aspen Neuroscience
  • Sera Prognostics
  • Afferent Pharmaceuticals
  • Sebacia
  • Omniome
  • Xagenic
  • Fractyl Laboratories
  • Axial Biotherapeutics
  • Seraphina Therapeutics
  • ChromaCode
  • Achaogen
  • Milestone Pharmaceuticals
  • Evofem Biosciences
  • Applied Proteomics
  • Apnex Medical
  • Bionano Genomics
  • Smart Medical Systems
  • Twelve
  • Nobias Therapeutics
  • RightCare Solutions
  • Antios Therapeutics
  • Adynxx
  • Tandem Diabetes Care
  • Glaukos
  • Otonomy
  • Singular Genomics
  • aTyr Pharma
  • ROX Medical
  • Iterum Therapeutics
  • Syndax Pharmaceuticals